对于癌症病人，我觉得你一定要检视你自己的生活方式，但并不是说改变了生活方式就一定有用，还是得看情况，该手术还是得手术，该放化疗的还是要放化疗。如果应该手术，千万不要拖延。
我其实特别幸运，因为我及时去做了检测，在癌细胞只有1.1毫米时就发现了，而且因为癌细胞不太活跃，拖一阵子也还行。其实我的癌细胞自检是摸不出的，就算是mammogram的片子，也得要有经验的医生才能看出。我真的是很幸运，在对的时间碰见对的医生，做了对的选择。
另外，自检很重要，特别是对于发展快的癌细胞，真的可以摸出来。
下面附上我的病理检验结果：
Right breast mass at 10 o'clock, N5, MRI-guided core biopsy:
A small focus (1.1 mm on glass slides) of invasive carcinoma focally
identified with the following features:
Histologic type: Ductal, no special type.
Histologic grade (Nottingham histologic score): Intermediate grade, 2 of
3, (score 6 of 9).
Tubule formation: Poor, 3 of 3.
Nuclear grade: Intermediate, 2 of 3.
Mitotic rate: Low, 1 of 3.
Lymph-vascular invasion: Not identified.
Ductal carcinoma in situ (DCIS): Present.
Architectural pattern: Solid and cribriform with involvement of lobules.
Nuclear grade: Intermediate.
Necrosis: Not identified.
Associated calcifications: Present.
Additional findings:
Focal flat epithelial atypia and atypical ductal hyperplasia (ADH).
Dense stromal fibrosis and pseudoangiomatous stromal hyperplasia (PASH
).
Immunohistochemical studies for estrogen/progesterone receptor
expression, HER-2/neu overexpression and proliferation index
determination (Ki-67) will be performed and reported in an addendum.
DIAGNOSIS COMMENT:
This right breast mass at 10 o'clock MRI-guided core biopsy
predominantly shows foci of ductal carcinoma in situ (DCIS) with
background stromal fibrosis. A small focus of invasive ductal carcinoma
is focally identified adjacent to DCIS, which measures up to 1.1 mm on
glass slides.
SUMMARY OF PREDICTIVE/PROGNOSTIC MARKERS:
Estrogen Receptor Status: Positive (99% with strong nuclear staining)
Progesterone Receptor Status: Positive (99% with strong nuclear
staining)
HER2 (by immunohistochemistry): Negative (score of 0)
HER2 (by in situ hybridization): Not performed
Proliferation Index (Ki-67): 6%